PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS
PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises admin...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DORMAN, GYOERGY JEDNAKOVITS, ANDREA UEROEGDI, LASZLO MARVANYOS, EDE SINKA, MARTA ERDOE, SANDOR BACSY, ERNOE VITAI, MARTA KURUCZ, ISTVAN SCHMIDT, GYOERGY KORANYI, LASZLO BARABAS, MIHALY TOEROEK, MAGDOLNA |
description | PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises administering to a patient a product comprising hydroxylamine derivatives of the general formulae (I) with the proviso that in the compounds of general formula (I) when X comprises a -NR3R4 group and Y comprises a hydroxyl group, the X group is condensed with the Y substituent to form an intramolecular ring represented by general formula (Ill) |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0966283A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0966283A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0966283A23</originalsourceid><addsrcrecordid>eNqNjUsKwkAQRLNxIeod-gKCJBB0OfR0nIFOT5hPXIYg40o0EBce3wgewFVRrx7Uunh3RvlWIaVoUTF03umEMUDjPGDyVs6gRC-cepL4rZZZKAQKgE6EMJKGi40GoiFoFTdJMFon4BroVcDEygOJdsvOdvlAYg7bYnUb73Pe_XJTQEMRzT5PzyHP03jNj_waqDuc6ro8Vqqs_lA-Ymk5_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS</title><source>esp@cenet</source><creator>DORMAN, GYOERGY ; JEDNAKOVITS, ANDREA ; UEROEGDI, LASZLO ; MARVANYOS, EDE ; SINKA, MARTA ; ERDOE, SANDOR ; BACSY, ERNOE ; VITAI, MARTA ; KURUCZ, ISTVAN ; SCHMIDT, GYOERGY ; KORANYI, LASZLO ; BARABAS, MIHALY ; TOEROEK, MAGDOLNA</creator><creatorcontrib>DORMAN, GYOERGY ; JEDNAKOVITS, ANDREA ; UEROEGDI, LASZLO ; MARVANYOS, EDE ; SINKA, MARTA ; ERDOE, SANDOR ; BACSY, ERNOE ; VITAI, MARTA ; KURUCZ, ISTVAN ; SCHMIDT, GYOERGY ; KORANYI, LASZLO ; BARABAS, MIHALY ; TOEROEK, MAGDOLNA</creatorcontrib><description>PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises administering to a patient a product comprising hydroxylamine derivatives of the general formulae (I) with the proviso that in the compounds of general formula (I) when X comprises a -NR3R4 group and Y comprises a hydroxyl group, the X group is condensed with the Y substituent to form an intramolecular ring represented by general formula (Ill)</description><edition>6</edition><language>eng ; fre ; ger</language><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991229&DB=EPODOC&CC=EP&NR=0966283A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991229&DB=EPODOC&CC=EP&NR=0966283A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DORMAN, GYOERGY</creatorcontrib><creatorcontrib>JEDNAKOVITS, ANDREA</creatorcontrib><creatorcontrib>UEROEGDI, LASZLO</creatorcontrib><creatorcontrib>MARVANYOS, EDE</creatorcontrib><creatorcontrib>SINKA, MARTA</creatorcontrib><creatorcontrib>ERDOE, SANDOR</creatorcontrib><creatorcontrib>BACSY, ERNOE</creatorcontrib><creatorcontrib>VITAI, MARTA</creatorcontrib><creatorcontrib>KURUCZ, ISTVAN</creatorcontrib><creatorcontrib>SCHMIDT, GYOERGY</creatorcontrib><creatorcontrib>KORANYI, LASZLO</creatorcontrib><creatorcontrib>BARABAS, MIHALY</creatorcontrib><creatorcontrib>TOEROEK, MAGDOLNA</creatorcontrib><title>PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS</title><description>PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises administering to a patient a product comprising hydroxylamine derivatives of the general formulae (I) with the proviso that in the compounds of general formula (I) when X comprises a -NR3R4 group and Y comprises a hydroxyl group, the X group is condensed with the Y substituent to form an intramolecular ring represented by general formula (Ill)</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUsKwkAQRLNxIeod-gKCJBB0OfR0nIFOT5hPXIYg40o0EBce3wgewFVRrx7Uunh3RvlWIaVoUTF03umEMUDjPGDyVs6gRC-cepL4rZZZKAQKgE6EMJKGi40GoiFoFTdJMFon4BroVcDEygOJdsvOdvlAYg7bYnUb73Pe_XJTQEMRzT5PzyHP03jNj_waqDuc6ro8Vqqs_lA-Ymk5_A</recordid><startdate>19991229</startdate><enddate>19991229</enddate><creator>DORMAN, GYOERGY</creator><creator>JEDNAKOVITS, ANDREA</creator><creator>UEROEGDI, LASZLO</creator><creator>MARVANYOS, EDE</creator><creator>SINKA, MARTA</creator><creator>ERDOE, SANDOR</creator><creator>BACSY, ERNOE</creator><creator>VITAI, MARTA</creator><creator>KURUCZ, ISTVAN</creator><creator>SCHMIDT, GYOERGY</creator><creator>KORANYI, LASZLO</creator><creator>BARABAS, MIHALY</creator><creator>TOEROEK, MAGDOLNA</creator><scope>EVB</scope></search><sort><creationdate>19991229</creationdate><title>PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS</title><author>DORMAN, GYOERGY ; JEDNAKOVITS, ANDREA ; UEROEGDI, LASZLO ; MARVANYOS, EDE ; SINKA, MARTA ; ERDOE, SANDOR ; BACSY, ERNOE ; VITAI, MARTA ; KURUCZ, ISTVAN ; SCHMIDT, GYOERGY ; KORANYI, LASZLO ; BARABAS, MIHALY ; TOEROEK, MAGDOLNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0966283A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>1999</creationdate><toplevel>online_resources</toplevel><creatorcontrib>DORMAN, GYOERGY</creatorcontrib><creatorcontrib>JEDNAKOVITS, ANDREA</creatorcontrib><creatorcontrib>UEROEGDI, LASZLO</creatorcontrib><creatorcontrib>MARVANYOS, EDE</creatorcontrib><creatorcontrib>SINKA, MARTA</creatorcontrib><creatorcontrib>ERDOE, SANDOR</creatorcontrib><creatorcontrib>BACSY, ERNOE</creatorcontrib><creatorcontrib>VITAI, MARTA</creatorcontrib><creatorcontrib>KURUCZ, ISTVAN</creatorcontrib><creatorcontrib>SCHMIDT, GYOERGY</creatorcontrib><creatorcontrib>KORANYI, LASZLO</creatorcontrib><creatorcontrib>BARABAS, MIHALY</creatorcontrib><creatorcontrib>TOEROEK, MAGDOLNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DORMAN, GYOERGY</au><au>JEDNAKOVITS, ANDREA</au><au>UEROEGDI, LASZLO</au><au>MARVANYOS, EDE</au><au>SINKA, MARTA</au><au>ERDOE, SANDOR</au><au>BACSY, ERNOE</au><au>VITAI, MARTA</au><au>KURUCZ, ISTVAN</au><au>SCHMIDT, GYOERGY</au><au>KORANYI, LASZLO</au><au>BARABAS, MIHALY</au><au>TOEROEK, MAGDOLNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS</title><date>1999-12-29</date><risdate>1999</risdate><abstract>PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises administering to a patient a product comprising hydroxylamine derivatives of the general formulae (I) with the proviso that in the compounds of general formula (I) when X comprises a -NR3R4 group and Y comprises a hydroxyl group, the X group is condensed with the Y substituent to form an intramolecular ring represented by general formula (Ill)</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP0966283A2 |
source | esp@cenet |
title | PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A47%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DORMAN,%20GYOERGY&rft.date=1999-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0966283A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |